9 ECV and T1 mapping in repaired tetralogy of fallot – CMR diffuse fibrosis measurement needs the right method for the right ventricle?
File(s)
Author(s)
Type
Poster
Abstract
Introduction It is increasingly appreciated applying parametric mapping to the RV has inherent challenges.
Methods We studied native LV and RV T1 mapping and ECV measures at 1.5 T in repaired tetralogy of Fallot (rTOF) patients (n=44, 24 male, 32±14 years, 35 (80%), NYHA class I). Single slices targeted perpendicular to to the LV septum or RV inferior wall using 11HB-MOLLI (6 mm slice thickness/TR 279 ms/TE 1.1 ms/Flip-angle 35°). Like image planes were repeated using ‘high sensitivity native T1’ 14HB-MOLLI (6 mm slice thickness/TR 300 ms/TE 1.1 ms/Flip-angle 5°) in attempt to improve sensitivity to tissue collagen. Haematocrit for ECV calculation was obtained within a few hours of CMR.
Results RVECV correlated with LVECV (r=0.7; p<0.001). Nineteen (46%) had increased RVECV (>35%) and 3 (8%) increased LVECV (>30%). Associations with all standard risk factors in rTOF were tested. RVECV correlated with right atrial area, (r=0.4; p<0.05). ‘High-sensitivity native T1’ correlated with akinetic RVOT length (r=0.6; p<0.05), and left atrial area (r=0.3; p=0.07) and QRS duration (r=0.3; p=0.4). RVECV did not correlate with high-sensitivity’ native T1. No diffuse RV fibrosis measure correlated with ejection fraction.
Conclusion Diffuse fibrosis was only associated with increased right atrial and RVOT akinetic area size which if true may relate to RV diastolic dysfunction. Given the lack of consistency of findings between techniques more data are needed, including determination of how the measures obtained relate to myocardial composition. Despite best efforts to obtain optimum RV T1 maps these findings suggest current approaches have limited use and dedicated RV sequence development is required.
Methods We studied native LV and RV T1 mapping and ECV measures at 1.5 T in repaired tetralogy of Fallot (rTOF) patients (n=44, 24 male, 32±14 years, 35 (80%), NYHA class I). Single slices targeted perpendicular to to the LV septum or RV inferior wall using 11HB-MOLLI (6 mm slice thickness/TR 279 ms/TE 1.1 ms/Flip-angle 35°). Like image planes were repeated using ‘high sensitivity native T1’ 14HB-MOLLI (6 mm slice thickness/TR 300 ms/TE 1.1 ms/Flip-angle 5°) in attempt to improve sensitivity to tissue collagen. Haematocrit for ECV calculation was obtained within a few hours of CMR.
Results RVECV correlated with LVECV (r=0.7; p<0.001). Nineteen (46%) had increased RVECV (>35%) and 3 (8%) increased LVECV (>30%). Associations with all standard risk factors in rTOF were tested. RVECV correlated with right atrial area, (r=0.4; p<0.05). ‘High-sensitivity native T1’ correlated with akinetic RVOT length (r=0.6; p<0.05), and left atrial area (r=0.3; p=0.07) and QRS duration (r=0.3; p=0.4). RVECV did not correlate with high-sensitivity’ native T1. No diffuse RV fibrosis measure correlated with ejection fraction.
Conclusion Diffuse fibrosis was only associated with increased right atrial and RVOT akinetic area size which if true may relate to RV diastolic dysfunction. Given the lack of consistency of findings between techniques more data are needed, including determination of how the measures obtained relate to myocardial composition. Despite best efforts to obtain optimum RV T1 maps these findings suggest current approaches have limited use and dedicated RV sequence development is required.
Date Issued
2018-05-01
Citation
2018
Copyright Statement
© 2018 The Author(s). This article has been accepted for publication in Heart following peer review. The definitive copyedited, typeset version: Ghonim S, Jenkins S, Smith GC, et al
9 ECV and T1 mapping in repaired tetralogy of fallot – CMR diffuse fibrosis measurement needs the right method for the right ventricle?
Heart 2018;104:A9, is available online at: http://dx.doi.org/10.1136/heartjnl-2018-BCVI.24
9 ECV and T1 mapping in repaired tetralogy of fallot – CMR diffuse fibrosis measurement needs the right method for the right ventricle?
Heart 2018;104:A9, is available online at: http://dx.doi.org/10.1136/heartjnl-2018-BCVI.24
Sponsor
British Heart Foundation
Identifier
http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000432593500025&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=1ba7043ffcc86c417c072aa74d649202
Grant Number
FS/11/38/28864
Source
Joint Meeting of the British-Society-of-Cardiovascular-Imaging/British-Society-of-Cardiovascular-CT, British-Society-of-Cardiovascular-Magnetic-Resonance and British-Nuclear-Cardiac-Society on British Cardiovascular Imaging
Subjects
Science & Technology
Life Sciences & Biomedicine
Cardiac & Cardiovascular Systems
Cardiovascular System & Cardiology